[1]刘纯岳,方俊粤,林帝金,等.儿童免疫性血小板减少症患者外周血B淋巴细胞亚群变化的研究[J].现代检验医学杂志,2018,33(06):59-62.[doi:10.3969/j.issn.1671-7414.2018.06.015]
　LIU Chun-yue,FANG Jun-yue,LIN Di-jin,et al.B Lymphocyte Subsets in Peripheral Blood of Patients with Pediatric Immune Thrombocytopenia[J].Journal of Modern Laboratory Medicine,2018,33(06):59-62.[doi:10.3969/j.issn.1671-7414.2018.06.015]
点击复制

儿童免疫性血小板减少症患者外周血B淋巴细胞亚群变化的研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
59-62
栏目:
论著
出版日期:
2018-12-24

文章信息/Info

Title:
B Lymphocyte Subsets in Peripheral Blood of Patients with Pediatric Immune Thrombocytopenia
文章编号:
1671-7414(2018)06-059-04
作者:
刘纯岳; 方俊粤; 林帝金; 鲍蕴文; 陆晓红; 林向华
中山大学孙逸仙纪念医院检验科,广州 510120
Author(s):
LIU Chun-yue; FANG Jun-yue; LIN Di-jin; BAO Yun-wen; LU Xiao-hong; LIN Xiang-hua
Department of Clinical Laboratory,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,Guangzhou 510120,China
关键词:
免疫性血小板减少症;  B淋巴细胞亚群;  CD38;  CD27;  CD19
分类号:
R558.2; R392.11
DOI:
10.3969/j.issn.1671-7414.2018.06.015
文献标志码:
A
摘要:
目的 探讨儿童免疫性血小板减少症患者(immune thrombocytopenia,ITP)外周血中CD38,CD27,CD19表达阳性的B淋巴细胞亚群的变化及临床意义。方法 选取2017年1月～12月中山大学孙逸仙纪念医院收治的初诊ITP患儿21例为初诊未治疗组(untreated ITP,U-ITP),完全缓解ITP患儿30例为完全缓解组(remission ITP,R-ITP)及同期健康体检儿童26例为健康对照组(normal control,NC),运用流式细胞术对其外周血B淋巴细胞亚群进行检测并与ITP患儿的PLT计数进行相关性分析。结果 外周血总CD19+B淋巴细胞比例:U-ITP组显著高于R-ITP组和NC组(F=7.543,P<0.01)。外周血CD19+CD27+CD38-记忆性B细胞占CD19+B细胞百分率:U-ITP组显著高于R-ITP组和NC组(F=8.876,P<0.001)。CD19+CD27-CD38-初始B细胞占CD19+B细胞百分率:U-ITP组显著低于R-ITP组)和NC组(F=5.058,P<0.01)。CD19+CD27+CD38+浆母细胞百分率:U-ITP组显著高于R-ITP组和NC组(F=9.588,P<0.001),而R-ITP组与NC组比较,B淋巴细胞各分群差异均无统计学意义(F=0.842～1.258,均P>0.05)。PLT计数与总CD19+ B细胞百分率呈负相关(r=-0.318,P=0.007),与CD19+CD27+CD38-记忆性B细胞百分率呈负相关(r=-0.444,P=0.000),与CD19+CD27-CD38-初始B细胞百分率呈正相关(r=0.416,P=0.000),与CD19+CD27+CD38+浆母细胞百分率呈负相关(r=-0.442,P=0.000)。结论 B淋巴细胞亚群在ITP患儿体内分布存在异常,其检测能够为ITP患儿临床疾病监测与判断预后提供重要的指导作用。
Abstract:
Objective To investigate the change and clinical significance of B lymphocyte subsets marked by CD38,CD27 and CD19 in peripheral blood of pediatric patients with immune thrombocytopenia.MethodsA total of 51 ITP patients(21 patients were newly diagnosed and untreated.30 patients were in remission)were collected from January 2017 to December 2017 in Sun Yat-Sen Memorial Hospital,and 26 normal controls were enrolledin this study.The abnormal of B lymphocyte subsets in peripheral blood of research cohort were detected by flow cytometry and their correlations with plateletcount were analyzed.Results The percentage of total CD19+B cells of untreated ITP patients was significantly higher than that of remission ITP patients and normal controls(F=7.543,P<0.01).The percentage ofmemory B cells in CD19+B cells of untreated ITP patients was significantly higher than that of remission ITP patients and normal controls(F=8.876,P<0.001).The percentage of naive B cells in CD19+B cells of untreated ITP patients was significantly lower than that of remission ITP patients and normal controls(F=5.058,P<0.01).The percentage of plasmablasts cells of untreated ITP patients was significantly higher than that of remission ITP patients and normal controls(F=9.588,P<0.001).There was no significant difference in Blymphocyte subsets between remission ITP patients and the normal controls(F=0.842～1.258,all P>0.05).The PLT count had significantly negative correlation with the percentage of total CD19+B cells(r=-0.318,P=0.007),memory B cells(r=-0.444,P=0.000),plasmablasts cells(r=-0.442,P=0.000)and had significantly positive correlation with naive B cells(r=0.416,P=0.000).Conclusion The distribution of B lymphocytesubsets was abnormal in ITP patients.The detection of B lymphocyte subsets canbe used as a useful indicator of clinical disease surveillance and prognosis inITP patients.

参考文献/References:

[1] Glanz J,France E,Xu S,et al.A population-based,multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children[J].Pediatrics,2008,121(3):e506-512.
[2] Giordano P,Cascioli S,Lassandro G,et al.B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy[J].Pediatric Research,2016,79(2):262-270.
[3] 中华医学会儿科学分会血液学组,《中华儿科杂志》编缉委员会.儿童原发性免疫性血小板减少症诊疗建议[J].中华儿科杂志,2013,51(5):382-384.
The Subspecialty Group of Hematology,The Society of Pediatrics,Chinese Medical Association,The Editorial Board,Chinese Journal of Pediatrics.Recommendations for diagnosis and treatment of primary immune thrombocytopenia inchildren[J].Chinese Journal of Pediatrics,2013,51(5):382-384.
[4] Nazy I,Kelton JG,Moore JC,et al.Autoantibodies to thrombopoietin andthe thrombopoietin receptor in patients with immune thrombocytopenia[J].British Journal of Haematology,2018,181(suppl 1):234-241.
[5] Olsson B,Andersson PO,Jernas M,et al.T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura[J].Nat Med,2003,9(9):1123-1124.
[6] Panitsas FP,Theodoropoulou M,Kouraklis A,et al.Adult chronic idiopathic thrombocytopenic purpura(ITP)is the manifestation of a type-1 polarized immune response[J].Blood,2004,103(7):2645-2647.
[7] Rocha AM,Souza C,Rocha GA,et al.The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia[J].Haematologica,2011,96(10):1560-1564.
[8] Stasi R,Cooper N,Del Poeta G,et al.Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab[J].Blood,2008,112(4):1147-1150.
[9] Jernas M,Hou Y,Stromberg Celind F,et al.Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP[J].Blood,2013,122(10):1789-1792.
[10] Zhu XJ,Shi Y,Zhang F,et al.Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia[J].British Journal of Haematology,2014,166(5):783-791.
[11] Kim Y,Ryu J,Ryu MS,et al.C-reactive protein induces G2/M phase cellcycle arrest and apoptosis in monocytes through the up regalation of B-cell translocation gene 2 expression[J].FEBS Lett,2014,588(4):625-631.
[12] Martinez-Gamboa L,Mei H,Loddenkemper,et al.Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopeniapurpura[J].Clinical Immunology,2009,130(2):199-212.
[13] Lyu M,Hao Y,Li Y,et al.Upregulation of CD72 expression on CD19+CD27+ memory B cells by CD40L in primary immune thrombocytopenia[J].British Journal of Haematology,2017, 178(2):308-318.
[14] Dorner T.Crossroads of B cell activation in autoimmunity:rationale oftargeting B cells[J].The Journal of Rheumatology Supplement,2006,77(3):3-11.
[15] Roll P,Palanichamy A,Kneitz C,et al.Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis[J].Arthritis and Rheumatism,2006,54(8):2377-2386.
[16] Warnatz K,Denz A,Drager R,et al.Severe deficiency of switched memoryB cells [CD27(+)IgM(-)IgD(-)] in subgroups of patients with common variable immunodeficiency:a new approach to classify a heterogeneous disease[J].Blood,2002,99(5):1544-1551.

相似文献/References:

[1]李腾达,刘鹏,谷明莉,等.sCD93在免疫性血小板减少症患者中表达升高及临床意义[J].现代检验医学杂志,2016,31(06):115.[doi:10.3969/j.issn.1671-7414.2016.06.033]
　LI Teng-da,LIU Peng,GU Ming-li,et al.Higher Expression of Soluble CD93 in Patients with Immune Thrombocytopenia and Clinical Significance[J].Journal of Modern Laboratory Medicine,2016,31(06):115.[doi:10.3969/j.issn.1671-7414.2016.06.033]
[2]李腾达a,司 宇a,刘 鹏a,等.Gas6在免疫性血小板减少症患者中表达增高及临床意义[J].现代检验医学杂志,2017,32(03):37.[doi:10.3969/j.issn.1671-7414.2017.03.010]
　LI Teng-daa,SI Yua,LIU Penga,et al.Increased Expression of Gas6 in Patients with Immune Thrombocytopenia and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(06):37.[doi:10.3969/j.issn.1671-7414.2017.03.010]
[3]王 瑶,左 斌,阮长耿,等.免疫性血小板减少症中血小板生成与清除研究进展[J].现代检验医学杂志,2019,34(03):161.[doi:10.3969/j.issn.1671-7414.2019.03.042]
　WANG Yao,ZUO Bin,RUAN Chang-geng,et al.Recent Advances of Platelet Clearance and Thrombocytopoiesis in ITP[J].Journal of Modern Laboratory Medicine,2019,34(06):161.[doi:10.3969/j.issn.1671-7414.2019.03.042]

备注/Memo

备注/Memo:
作者简介:刘纯岳(1986-),男,本科,检验技师,主要从事生物化学及免疫方面的工作及研究,E-mail:738703822@qq.com。
通讯作者:林向华,E-mail:13826068632@163.com。
更新日期/Last Update: 2018-11-30